These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15850305)

  • 1. [False low oximetry reading caused by patent blue vital dye during breast surgery].
    Nasif LA; Campos JM; Piñol S; Delgado MO; Casas JI; Landeira JM
    Rev Esp Anestesiol Reanim; 2005 Mar; 52(3):169-71. PubMed ID: 15850305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative decrease in pulse oximeter readings following injection of isosulfan blue.
    Hoskin RW; Granger R
    Can J Anaesth; 2001 Jan; 48(1):38-40. PubMed ID: 11212047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [False decrease in pulse oximetry readings due to patent blue in a patient with breast cancer].
    Murakami T; Kayo R; Kajita I; Cho S; Saito H
    Masui; 2003 Aug; 52(8):909-11. PubMed ID: 13677292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent blue sentinel node mapping in cervical cancer patients may lead to decreased pulse oximeter readings and positive methaemoglobin results.
    Kieckbusch H; Coldewey SM; Hollenhorst J; Haeseler G; Hillemanns P; Hertel H
    Eur J Anaesthesiol; 2008 May; 25(5):365-8. PubMed ID: 18272013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on oximetry of dyes used for sentinel lymph node biopsy.
    Piñero A; Illana J; García-Palenciano C; Cañizarese F; Canteras M; Cañadillas V; Durán E; Parilla P
    Arch Surg; 2004 Nov; 139(11):1204-7. PubMed ID: 15546820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of patent blue dye with pulse oximetry readings, methemoglobin measurements, and blue urine in sentinel lymph node mapping: a case report and review of the literature.
    Lai HC; Hsu HM; Cherng CH; Lin SL; Wu CT; Yu JC; Yeh CC
    Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):162-4. PubMed ID: 22221691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse oximeter changes with sentinel lymph node biopsy in breast cancer.
    El-Tamer M; Komenaka IK; Curry S; Troxel AB; Ditkoff BA; Schnabel FR
    Arch Surg; 2003 Nov; 138(11):1257-60. PubMed ID: 14609878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE
    Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic application of patent blue V in sentinel lymph node biopsy for breast cancer - Is it time for a change?
    Vidya R; Athwal R; Huissoon AP; Baretto RL; Thirumala Krishna M
    Indian J Cancer; 2019; 56(3):269-270. PubMed ID: 31389393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node mapping affects intraoperative pulse oximetric recordings during breast cancer surgery.
    Koivusalo AM; Von Smitten K; Lindgren L
    Acta Anaesthesiol Scand; 2002 Apr; 46(4):411-4. PubMed ID: 11952442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pulse oximetry after patent blue dye injection into the uterine cervix.
    Vieira SC; Sousa RB; Tavares MB; de Abreu BA; Ibiapina JO; de Sousa Oliveira AK; Zeferino LC
    Ann Surg Oncol; 2008 Oct; 15(10):2862-6. PubMed ID: 18696155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse oximetry and patent blue vital dye.
    Lee BB
    Acta Anaesthesiol Scand; 2003 Apr; 47(4):491; author reply 491. PubMed ID: 12694153
    [No Abstract]   [Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
    van Wessem KJ; Meijer WS
    Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immediate patent blue-induced hypersensitivity during sentinel node detection: The value of cutaneous tests].
    Jeudy G; Louvier N; Rapennes T; Goujon E; Fraisse J; Dalac-Rat S; Collet E
    Ann Dermatol Venereol; 2008; 135(6-7):461-5. PubMed ID: 18598795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factitious oxygen desaturation after isosulfan blue injection.
    Heinle E; Burdumy T; Recabaren J
    Am Surg; 2003 Oct; 69(10):899-901. PubMed ID: 14570371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The sentinal node: the Dijon experience].
    Hoyek T; Benoit L; Fraisse J
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):565-71. PubMed ID: 12407328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer.
    Govaert GA; Oostenbroek RJ; Plaisier PW
    Eur J Surg Oncol; 2005 May; 31(4):373-5. PubMed ID: 15837042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.